CAD031 is a derivative of the Alzheimer's disease (AD)-targeting agent J147 (HY-13779), exhibiting neuroprotective and memory-enhancing properties; it enhances memory in mice, improves dendritic structure, stimulates cell proliferation in the neurogenic regions of aged mouse brains, and demonstrates greater activity than J147 in human neural stem cell assays.